Lung cancer, lung benign mass, mediastinal mass, etc.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria (1) 18 years old <= age <=80 years old; (2) Endoscopic thoracic surgery with corresponding surgical indications, including but not limited to the following operations: segmental/lobectomy, mediastinal tumor resection; (3) Patients whose physiological condition is acceptable for thoracoscopic surgery; (4) Willing to cooperate with and complete the study follow-up and related tests; (5) The subjects or their agents voluntarily participate in the experiment and sign the informed consent in person.
Exclusion criteria
Exclusion criteria: Exclusion criteria (1) Pregnant or lactating women; (2) The clinical stage of malignant tumor is IV; (3) Patients in need of emergency surgery; (4) Active bleeding, abnormal coagulation function (prothrombin time (PT) or International normalized ratio (INR) is 1.5 times higher than the upper limit of normal) or platelet count < 80×10^9/L; (5) Patients with serious cardiovascular or circulatory diseases who cannot tolerate surgery; (6) Participants in other clinical trials within the last 1 month; (7) Unable to understand the trial requirements, or unable to complete the study follow-up plan; (8) The researcher believes that there are other circumstances that are not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Remote surgery success rate;Network transmission evaluation (network signal delay, total delay, packet loss rate); | — |
Secondary
| Measure | Time frame |
|---|---|
| Robot-assisted surgery time;Intraoperative blood loss;Catheter drainage time;Postoperative hospital stay;Postoperative pain score;Evaluation of the operative psychological load of the surgeon;Subjective evaluation of intraoperative experience;Postoperative complication;Device failure rate; | — |
Countries
China
Contacts
Gansu Provincial People's Hospital